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Abstract
Objectives: To analyze the soft tissue morphology under healthy and experimental mucositis 
conditions comparing zirconia and titanium implants.
Methods: Forty-two patients with two adjacent missing teeth received one zirconia (Zr) and 
one titanium (Ti) implant, with the mesial and distal position randomized. At 3 months, half 
of the patients were instructed to continue (healthy; h) and the other half to omit 
(experimental mucositis; m) oral hygiene around the implants for 3 weeks. Clinical 
parameters were evaluated before and after the experimental phase and a soft tissue biopsy 
was harvested. Mixed model analyses were performed to analyze the data.
Results: The plaque control record increased significantly for the two mucositis groups, 
reaching 68.3±31.9% (mean±standard deviation) for Zr-m and 75.0±29.4% for Ti-m 
(p<0.0001), being also significantly lower for Zr-m than for Ti-m. Bleeding on probing 
remained stable in group Zr-m and amounted to 21.7±23.6%, but increased significantly in 
group Ti-m (p=0.040), measuring 32.5±27.8%. The number of inflammatory cells and the 
length of the junctional epithelium did not significantly differ between the groups.
Conclusion:
Both implants rendered similar outcomes under healthy conditions. Lower plaque and 
bleeding scores were detected for zirconia implants under experimental mucositis conditions. 
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Clinical Relevance
Scientific rationale for the study: Zirconia dental implants have drawn attention as a metal-
free solution in implant dentistry during the last decade. Zirconium dioxide is claimed to be a 
material with favorable properties in terms of soft tissue integration. Currently, clinical data 
on a histological level is scarce and settings comparing the material directly with titanium 
implants are lacking.
Principal findings: Zirconia implants rendered similar outcomes under healthy conditions, but 
lower plaque and bleeding scores were detected under experimental mucositis conditions. 
Histologically, only minimal differences were observed between zirconia and titanium 
implants.
Practical implications: With focus on soft tissue integration, slightly more favorable clinical 
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Introduction
Dental implants offer a predictable treatment modality for replacing single or multiple missing 
teeth with the ultimate goal to restore function, comfort and esthetics of the patient (Jung, 
Zembic, Pjetursson, Zwahlen, & Thoma, 2012; Pjetursson, Thoma, Jung, Zwahlen, & Zembic, 
2012). Titanium and titanium alloys are considered the gold standard due to favorable 
physico-chemical properties, their biological attributes allowing for osseointegration and the 
long-term documentation in oral implantology (Branemark et al., 1977; Schroeder, Pohler, & 
Sutter, 1976).
Despite the overall promising outcomes, some implants display bone loss or even fail after 
successful initial osseointegration (De Bruyn et al., 2017). Plaque-induced inflammation is 
proven to have a cause-effect relationship on bone loss and might be considered the most 
important or at least most thoroughly studied factor (Lindhe, Berglundh, Ericsson, Liljenberg, 
& Marinello, 1992). More recently, further mechanisms have been studied, mainly considering 
immune-osteolytic responses inducing bone loss (Albrektsson, Canullo, Cochran, & De Bruyn, 
2016). The presence of free titanium particles around implants was proven in preclinical 
models (Guglielmotti et al., 2015; Schliephake, Reiss, Urban, Neukam, & Guckel, 1993) and 
is together with biocorrosion of titanium (Barão et al., 2012) a potential trigger, by leading to 
free ions and thereby inducing the interleukin-1ß pathway (Pettersson et al., 2017). However, 
there is currently insufficient evidence to state a clear cause-effect relationship in clinical 
scenarios (Mombelli, Hashim, & Cionca, 2018).
Zirconium dioxide has the potential to overcome these issues due to its different material 
properties. Various preclinical and clinical trials demonstrated zirconia dental implants to 
fulfill the basic principles for successful osseointegration (Balmer et al., 2020; Balmer et al., 
2018; Depprich et al., 2008; Kohal, Weng, Bachle, & Strub, 2004; Oliva, Oliva, & Oliva, 
2007). In addition, several preclinical and clinical reports indicate advantages of zirconium 
dioxide on the soft tissue level: i) Limited evidence is available demonstrating that zirconia 
exhibits lower bacterial colonization potential compared to titanium (Roehling et al., 2017; 
Scarano, Piattelli, Caputi, Favero, & Piattelli, 2004). ii) Favorable soft tissue responses were 
reported for zirconia abutments in preclinical studies in terms of soft tissue thickness, length 
of the junctional epithelium and marginal bone loss (Abrahamsson, Berglundh, Glantz, & 
Lindhe, 1998; Welander, Abrahamsson, & Berglundh, 2008). iii) A recent canine model 
revealed significantly less bone loss in a ligature-induced plaque accumulation model for 
zirconia compared to titanium implants (Roehling et al., 2019). iv) Improved epithelial 
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al., 2016).
The present clinical evidence for zirconia implants is limited to prospective trials in non-
controlled settings (Roehling, Schlegel, Woelfler, & Gahlert, 2018). 
Therefore, the aim of the present study was to clinically and histologically evaluate the soft 
tissue morphology under healthy and experimental mucositis conditions comparing zirconia 
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Material and Methods 
This study was designed as a prospective, randomized controlled clinical trial with two 
consecutive randomization processes resulting in four equal treatment groups. A total of 40 
patients were recruited for the present study. All patients gave written informed consent and 
research was performed according to the Helsinki protocol. The present study was approved 
by the local ethical committee KEK-ZH-Nr. 2015-0215 (PB_2016-01767) and is registered in 
the German Register of Clinical Trials (DRKS00008591).
Study population
Patients presenting at the Clinic of Reconstructive Dentistry were consecutively enrolled 
between June 2015 and February 2019. Prerequisite were two missing adjacent teeth in the 
maxilla or mandible in positions of premolars and molars with at least one tooth present 
adjacent to the edentulous space and the need/wish for a reconstruction on dental implants.
Inclusion criteria:
 Male and female patients 18 years to 80 years of age 
 No general medical condition which represents a contraindication to implant treatment 
 At least 10mm of vertical bone height in the mandible allowing for placement of an 
8mm implant (2mm safety distance to inferior alveolar nerve) 
 At least 6mm of vertical bone height in the maxilla allowing for placement of an 8mm 
implant (in combination with a simultaneous, transcrestal augmentation)
 At least 2mm of keratinized tissue 
Exclusion criteria: 
 Smoking of more than 15 cigarettes a day 
 Poor oral hygiene after hygienic phase (Plaque control record over 30%) 
 Active periodontal disease 
 Women who were pregnant or breast feeding at the date of inclusion 
Implant placement
Following the screening visit, patients were scheduled for implant placement. Before surgery, 
patients rinsed for 60 seconds with a solution containing 0.2% chlorhexidine 
(Kantonsapotheke Zürich, Zürich, Switzerland) and received 500mg of an analgesic 
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(Ultracain® D-S, Hoechst-Pharma AG, Zurich, Switzerland) and a mucoperiosteal flap was 
raised. The flap design consisted of sulcular incisions at the neighboring teeth and a crestal 
incision, which divided the keratinized tissue equally in the mandible, or connected the palatal 
line angles in the maxilla (Figure 1a). The implant bed was prepared according to the 
manufacturer’s instructions. After preparation with a Ø 3.5mm drill, a sealed envelope was 
opened containing the allocation of the implants according to a computer-generated list (n = 
20 per group, https://www.random.org/):
 Zirconia implant (ZrO2): PURE Ceramic Implant Monotype Ø 4.1mm, ZLA™ (Institut 
Straumann AG, Basel, Switzerland) made from yttrium-stabilized zirconium dioxide.
 Titanium implant (Ti): Standard Plus Implant Ø 4,1mm, Regular Neck Ø 4,8mm, 
SLA®, (Institut Straumann AG) made from commercially pure titanium.
Both implants featured a similar shape and a polished surface of their soft tissue component 
with 1.8mm of height. Selective profile drilling and thread tapping was performed according 
to the implant allocation, the local bone density and the shape of the surrounding crestal 
bone. Subsequently, implants were placed with a maximum torque of 35NCM for zirconia and 
50NCM for titanium implants (Figure 1b). For the zirconia implants, the abutment height 
(4mm or 5.5mm) was selected depending on the occlusal clearance.
In case of thin buccal bone plates (< 1.5mm), dehiscence or fenestration defects, a guided 
bone regeneration procedure (GBR) was performed. Deproteinized bovine bone mineral 
(DBBM; Bio-Oss®, Geistlich Pharma AG) granules and/or DBBM with 10% Collagen (Bio-Oss® 
Collagen, Geistlich Pharma AG) was used in combination with a native collagen membrane 
(Bio-Gide®, Geistlich Pharma AG), optionally fixed with resorbable pins (LeadFIX, ImperiOs, 
Bad Homburg, Germany). In case of transcrestal sinus elevation, DBBM with 10% collagen 
(Bio-Oss® Collagen, Geistlich Pharma AG) was used. All implants healed transmucosally. 
Horizontal mattress sutures and single interrupted sutures (Gore-tex® 5/0, W.L. Gore & 
Associates, Flagstaff, AZ, USA) adapted the tissues and secured the position of the flap 
(Figure 1c).
Postoperatively, patients rinsed with a solution containing 0.2% chlorhexidine 
(Kantonsapotheke Zürich) twice per day for seven days. Analgesics (Mefenacid, Streuli 
Pharma) were provided and used according the patient’s individual needs. In case of 
application of a biomaterial, patients received 750mg of amoxicilline (Amoxicillin Sandoz, 
Sandoz, Basel, Switzerland) three times per day for 5 days. Inspection of the surgical site 
and suture removal was performed after 7-10 days. Thereafter, patients were instructed to 
start cleaning the site gently with a soft toothbrush for another three weeks, before regular 
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Experimental mucositis 
Three months after implant placement, patients returned for all baseline (BL) measurements 
and the second randomization cycle. A microbiological sample was retrieved at the mesial or 
distal aspect of the implant (always facing the other implant) with a sterile paper point, after 
removing supragingival plaque. Plaque control record (PCR), probing depth (PD) and bleeding 
on probing (BoP) was recorded at six sites of each implant. Keratinized tissue (KT) was 
recorded buccally of each implant. 
Thereafter, an experimental mucositis phase followed for a duration of three weeks. The 
experiment was conducted as first described around teeth (Loe, Theilade, & Jensen, 1965), 
but also around implants in later studies (Chan, Pelekos, Ho, Cortellini, & Tonetti, 2019; Salvi 
et al., 2012). In case of an allocation to the healthy (h) group, patients were advised to 
continue cleaning and avoiding any alterations of their habits. In case of an allocation to the 
mucositis (m) group, patients were instructed to omit cleaning the site and the neighboring 
teeth and to avoid mouthrinses. The second randomization divided all sites into 4 equal 
groups: zirconia, healthy (Zr-h); titanium, healthy (Ti-h); zirconia, mucositis (Zr-m); 
titanium, mucositis (Ti-m).
At three weeks (3W), the measurements were repeated, prior to the harvesting a soft tissue 
biopsy. Healing abutments on titanium implants were removed and the sulcular area was 
cleaned gently with a foam pellet (Pele Tim, Voco GmbH, Cuxhaven, Germany) soaked with 
0.2% chlorhexidine (Kantonsapotheke Zürich). Scalers were used carefully whenever it was 
necessary to remove hard debris. Following local anesthesia (Ultracain® D-S, Hoechst-
Pharma AG), two parallel, crestal, full-thickness incisions connecting the buccal and oral line 
angles were performed (Figure 2a). The buccal and oral tissues were slightly mobilized before 
the buccal side of the biopsy was marked with a single interrupted suture (Premilene No. 7/0, 
B.Braun Melsungen AG) (Figure 2b+c). In order to prepare the prosthetic treatment, a PEEK 
cap was snapped onto the zirconia implant, and slight soft tissue adaptations were made if 
necessary. A suitable healing abutment was inserted onto the titanium implant and the soft 
tissues were adapted with an inverting, external mattress suture (Gore-tex® 5/0, W.L. Gore 
& Associates) (Figure 2d). Patients were advised to rinse with a solution containing 0.2% 
chlorhexidine (Kantonsapotheke Zürich) twice per day for seven days. Moreover, a dental 
adhesive paste was provided and the application was instructed to the patient (Solcoseryl, 
MEDA Pharmaceuticals, Wangen, Switzerland). Sutures were removed 7-10 days later and 
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A multiplex real-time polymerase chain reaction test was performed (IAI Pado Test, Institut 
IAI, Zuchwil, Switzerland). Bacterial ribosomal 16S rRNA was detected and allowed 
quantification of total bacterial load and presence of six periodontal marker pathogens 
(Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Tannerella forsythia, 
Treponema denticola, Prevotella intermedia, Filifactor alocis).
Histologic processing
After at least 48 hours in formalin, the specimens were dehydrated and infiltrated with xylol 
and paraffin (Paraffin at 60° Celsius). Before embedding the biopsy, the orientation suture 
was removed. A central section was cut into 2-5 μm thick sections with a microtome 
(MICROM, Medite GmbH, Dietlikon, Switzerland). Two sections of each biopsy were retrieved, 
one was stained with Hematoxylin-eosin and one with Elastica – Van Gieson.
Histologic assessment
A blinded pathologist performed a descriptive assessment using an optical microscope 
(Olympus CX41, Olympus Corporation, Tokyo, Japan). For each parameter, a scoring system 
ranging between 0 and 3 was applied. Parameters encompassed the number of neutrophil 
granulocytes, eosinophil granulocytes, lymphocytes, plasma cells and macrophages within the 
epithelium. In the lamina propria, neutrophil granulocytes, eosinophil granulocytes, 
lymphocytes, plasma cells, macrophages and collagen density were evaluated. 
Histomorphometric analysis
The analysis was performed by a blinded histologist using an optical microscope (Leica 
CTR600, Leica, Wetzlar, Germany) at 200x magnification. The length of the junctional 
epithelium was measured by following the surface of the epithelium (LAS V4.3, Leica). The 
overall soft tissue thickness was measured vertically (Figure 3a). Furthermore, the ratio of 
the two measurements was calculated and expressed as a percentage.
Four regions of interest, standardized in size, were placed along the peri-implant soft tissue 
interface of the titanium and zirconia implant (Figure 3a). The regions of interest were placed 
behind the epithelium at the following levels: oral epithelium, sulcular epithelium, junctional 
epithelium, supracrestal connective tissue (Thoma et al., 2018). An image editing software 
(Adobe Photoshop CS6 extended, Adobe Systems, San José, CA, USA) was used to mark 
inflammatory cells, fibroblasts, epithelium and background. The percentage of the area of all 
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Statistical analysis
Data was computed in Excel (Microsoft Corp., Redmond, WA, USA) and statistical analysis 
was performed with SAS 9.4 (SAS Corp., Cary NC. USA). Means and standard deviations as 
well as medians with quartiles were used to describe continuous variables, counts and 
percentages were used for categorical variables. The number of inflammatory cells at the 
level of the junctional epithelium was determined as the primary outcome and used as one of 
the dependent variables in the models (Berglundh et al., 1991). Parametric and mostly 
nonparametric linear mixed models (MM) (Brunner et al., 2001) were applied, depending on 
the satisfied model assumptions. The normality assumption was not holding for most of the 
parameters. The independent variables in all models were the group variables with the four 
groups Zr-h, Ti-h and Zr-m, Ti-m, sometimes also with time as a variable together with their 
interaction. The random effect was the patient because of the clustered data within a patient. 
Logistic mixed models were applied in order to analyze counts and percentages. In addition, 
to analyze possible confounding effects, more complex models consisted of the independent 
factors implant, cleaning and an additional variable of interest. Simple parametric or 
nonparametric linear models were based on the differences Ti - Zr within each patient. The 
level of significance was set at 5% and no correction for multiple testing for the several 
parameters was applied. For the pairwise comparisons of Ti - Zr under healthy and under 
mucositis conditions, 95%-confidence intervals were derived by parametric or nonparametric 
methods corresponding to the applied mixed model, applying also the Bonferroni correction 










This article is protected by copyright. All rights reserved
Results
A total of 42 patients were screened and participated in the study. They received 84 implants, 
which all healed successfully. One patient could not be further treated after implant 
placement due to aggravated general medical conditions. Another biopsy was excluded from 
the analysis due to insufficient quality. Forty biopsies were successfully analyzed. Baseline 
characteristics of these patients are summarized in Table 1. Median age amounted to 52.5 
years (first quartile (Q1) = 36.8; third quartile (Q3) = 61.3) for groups Zr-h/Ti-h and 62.1 
years (Q1 = 51.5; Q3 = 69.5) in groups Zr-m/Ti-m.
Clinical parameters
All descriptive results are reported in Table 2 and confidence intervals are given in Appendix 
2. At baseline, the plaque control record (PCR) as a dependent variable was significantly 
lower in group Zr-m with 4.2±7.4% (mean±standard deviation) as compared to the other 
three groups with values ranging from 10.8±21.1% and 14.2±27.2% (nonparam. MM: 
intergroup p=0.003). At 3W, significantly different values were obtained for the mucositis 
groups (nonparam. MM: intergroup p<0.001), amounting to 68.3±31.9% for Zr-m and 
75.0±29.4% for Ti-m, Ti-m also being significantly higher than Zr-m (p=0.039). These 
changes were also significant in time for these two groups (intragroup: p<0.001; p<0.001). 
PCR is also presented in Figure 4a.
At baseline, bleeding on probing (BoP) as a dependent variable was significantly lower in 
group Ti-m with 15.8±18.3% as compared to the other groups, which were ranging from 
20.8±18.6% to 22.5±23.7% (nonparam. MM: intergroup p=0.0157). The values decreased 
in the two healthy groups, since the measurements at 3W amounted to 11.7±18.8% in Zr-h 
and 11.7±16.3% in Ti-h (nonparam. MM: intragroup: p=0.025; p=0.481 and for the 3W 
data: nonparam. MM: intergroup p=0.554). BoP remained stable in group Zr-m with 
21.7±23.6% (nonparam. MM: intragroup p=0.8390), but increased significantly in group Ti-
m and amounted to 32.5±27.8% (nonparam. MM: intragroup: p=0.039), resulting in a 
significant difference when comparing the experimental mucositis groups at 3W (nonparam. 
MM: intergroup of the mucositis groups: p<0.001, and all 4 groups: p<0.001). BoP is also 
presented in Figure 4b.
Probing depth (PD) ranged between 2.6±0.5mm and 2.7±0.7mm in all BL measurements 
(param. MM: intergroup p=0.772). The values decreased slightly in all groups and measured 
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Microbiology
Total bacterial loads ranged from 15.3±15.0 millions to 29.1±28.7 millions in BL and 3W 
measurements (nonparam. MM intergroup: p=0.176 and p=0.334). The presence of a 
marker pathogen ranged between 0 out of 18 (0%; group Ti-m, BL) and 3 out of 15 (17%; 
group Zr-m, BL). There were no significant differences between groups (p>0.05, for both BL 
and 3W, based on logistic mixed models). Descriptive data is summarized in Appendix 1.
Descriptive Histology
A matured oral epithelium with few keratinized layers and with deep rete pegs was observed 
in the center of the biopsies, transiting into a distinct junctional epithelium towards the 
implants. The number of neutrophil granulocytes, eosinophil granulocytes, lymphocytes, 
plasma cells and macrophages in the epithelium was very low, only scores 0 and 1 were 
observed. The length of the junctional epithelium appeared to vary heavily between patients, 
but did merely differ when comparing the two sides of a biopsy facing the two implant 
surfaces (Figure 3b+c).
The lamina propria mainly consisted of dense collagen fibers with scores ranging from 
2.6±0.5 to 2.7±0.4 (Figure 3a-c). Only scores 0 and 1 were observed for neutrophil 
granulocytes, the frequency of score 1 ranged between 2 out of 20 (10%, Ti-h) and 4 out of 
20 (20%, Zr-h). Similar for the number of macrophages, maximum scores of 1 were found 
with a frequency of 10 out of 20 (50%, Ti-h and Ti-m) and 11 out of 20 (55%, Zr-h and Zr-
m). No eosinophil granulocytes were found despite one site with a score of 1 (group Ti-h). 
Higher scores were obtained for lymphocytes and plasma cells (lowest Ti-m: 1.1±0.5; 
highest Zr-h: 1.5±0.8 and Ti-h 1.5±0.7). Nine sites in 8 patients were scored with a 
maximum of 3 and showed a distinct infiltrate behind the junctional epithelium, mainly 
consisting of lymphocytes and plasma cells. Only one patient (Randomized as healthy, PCR: 
0%) showed an obvious infiltrate at both implants. Seven out of these 9 infiltrates were seen 
at a zirconia implant and 6 out of 9 were found in the healthy groups.
Histomorphometric analysis
All descriptive results are reported in Table 3 and confidence intervals are given in Appendix 
2. The primary outcome, the number of inflammatory cells at the level of the junctional 
epithelium, amounted to 4.8±5.7% in group Zr-h, 3.1±5.7% for Ti-h, 2.0±3.2 for Zr-m and 
2.2±3.1% for Ti-m (Figure 4c). The differences between the groups were not significant 
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Based on 22 evaluated biopsies, the length of the junctional epithelium amounted to 
1213.5±243.3µm for Zr-h, 1344.6±430.1µm for Ti-h, 1664.8±668.8µm for Zr-m and 
1557.6±473.3µm for Ti-m. The differences between the 4 groups were not significant 
(param. MM intergroup:p=0.161). 
The overall tissue thickness amounted to 1924.9±476.3µm for Zr-h, 2056.4±431.9µm for Ti-
h, 2484.8±431.3µm for Zr-m and 2387.2±510.4µm for Ti-m (param. MM intergroup: 
p=0.029). In particular using cleaning as explanatory variable, the comparison of the two 
cleaning groups showed a significant difference (param. MM cleaning: p=0.021).
The ratio of the two measurements ranged between 64.5±10.9% (Zr-h) and 66.7±22.1% 
(Zr-m), without significant differences (param. MM intergroup: p=0.985).
More complex mixed modelling
Because of the small sample size, a complex modelling for the primary outcome 
(inflammatory cells at the level of the junctional epithelium) with more than three variables 
was not reasonable. Hence, only one additional factor was added to the two considered 
factors cleaning and implant (i.e. the four study groups). Nonparametric MM of the primary 
outcome did not reveal significant effects of jaw, gender, smoking, BoP at 3W, PD at 3W and 
presence of a GBR.
Based on the differences (Ti – Zr) of the primary outcome and only one explanatory variable, 
the influence of cleaning (param. p=0.326), mean PI at 3W (param. p=0.608), mean PD at 
3W (parametric p=0.046), mean BoP at 3W (parametric p=0.449), mean length of the 
junctional epithelium (parametric p=0.769), ratio of the length of the junctional epithelium 
and overall tissue thickness were not significant (param. p=0.848). More parametric linear 
models with cleaning and an additional factor did not reveal any significant effects of these 
differences (Ti-Zr). 
Modelling was repeated, using the difference of the lengths of the junctional epithelium at BL 
and 3W as a dependent variable. None of the linear models, always including cleaning, 
revealed any significant influences (p>0.05), except for the mean number of fibroblasts at 
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Discussion
The present randomized controlled clinical trial revealed i) Overall very comparable outcomes 
for all four groups; ii) Clinically, a significant increase in plaque control record in the 
mucositis groups, with a significantly higher plaque control record for the titanium implant; 
iii) Clinically, a significant increase in BoP around titanium implants in the mucositis group, 
being also higher as compared to the zirconia implant; iv) Microbiologically, no differences 
and random appearance of marker pathogens; v) Histologically, no differences in terms of the 
number of inflammatory cells at the level of the junctional epithelium; vi) Histologically, an 
increase of tissue dimensions for the mucositis groups; vii) An association of higher probing 
depths with more inflammatory cells.
Zr-m reported a lower PCR and Ti-m a lower BoP at baseline, while the other three groups 
were similar. From a clinical point of view, the baseline values are considered comparable for 
zirconia and titanium implants under healthy conditions. However, under experimental 
mucositis conditions, results were more favorable for zirconia implants. The plaque control 
record remained lower and bleeding on probing did not increase, while there was a significant 
increase for titanium implants. Expressed in a more accessible way, 2-3 out of 12 sites bled 
in average around zirconia implants, while 4 out of 12 sites bled around a titanium implant 
under mucositis conditions.
Based on the results of the plaque control record, the experimental mucositis experiment 
worked very well. However, compared to other studies, the expression of inflammatory 
parameters was clearly lower (Chan et al., 2019; Loe et al., 1965). One reason might be that 
the implants were unrestored and did therefore not allow for the same amount of plaque 
accumulation. The second reason might be that no splint was provided to the patient to cover 
this area during oral hygiene procedures. Even though the difference was not very distinct in 
the present study, lower plaque accumulation and bleeding scores when comparing zirconia 
and titanium on the abutment level have been reported earlier (Sanz-Martín, Sanz-Sánchez, 
Carrillo de Albornoz, Figuero, & Sanz, 2018).
No trends were recognized for the microbiological outcomes. The variance for total bacterial 
loads was high, and the numbers did apparently not increase in the two experimental 
mucositis groups. Marker pathogens seemed to appear at random. No relation was detected 
when putting the result in context of the clinical situation or the histology of these patients. 
In contrast to the present results, a recently published study reported distinct differences 
based on only 16 patients (Clever et al., 2019). Samples were obtained for a tooth, a 
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found for zirconia in terms of total bacterial load as well as presence of Tannerella forsythia 
and Prevotella intermedia.
Most of the histological results are also exhibiting a large variance. This feature is in line with 
the experience of the descriptive histologic assessment, where factors between patients 
seemed to vary far more than between the four groups. But the number of inflammatory cells 
at the level of the junctional epithelium was clearly higher compared to the other evaluated 
regions, as expected from early preclinical studies (Berglundh et al., 1991; Lindhe et al., 
1992). Also clinical studies found the infiltrates mainly behind the junctional epithelium 
(Thoma et al., 2018). Most inflammatory cells were found in group Zr-h. This finding 
coincided with the descriptive histology, reporting more than half of the most distinct 
infiltrates in this group. While the other three groups reported similar outcomes, group Zr-h 
reported slightly inferior results not only for the inflammatory cells, but also for several 
histological scorings. The missing correlation between the clinical and histological results 
might be explained by the type of the infiltrate. The present lymphoplasmacytic infiltrates 
indicate an immunologic or chronic reaction rather than a reaction to bacterial inflammation, 
which would be related to a presence of neutrophil granulocytes.
Some trends were recognized with regards to the histometric assessment, when comparing 
the healthy and mucositis groups. Beside the high variance, the reduced number of 
measurements limited the power for these outcomes. Only biopsies with a continuous, fully 
intact junctional epithelium on both sides were evaluated. Interestingly, the two mucositis 
groups had a longer junctional epithelium as well as a significantly increased overall soft 
tissue thickness. Therefore, the ratio of the two factors was not affected. It can be speculated 
that this is not an elongation of the junctional epithelium, but an overall increase of the 
dimension probably due to oedema in the mucositis groups. In contrast to the present 
results, other studies reported a longer junctional epithelium and therefore an increased 
biologic width in six minipigs (Linares et al., 2016). This was interpreted as a positive feature, 
although the overall tissue thickness was similar, with titanium implants having a longer 
sulcular epithelium. Earlier preclinical studies did not find differences of these dimensions 
around zirconia and titanium abutments (Welander et al., 2008).
Very few interactions were recognized to explain an association of clinical and histological 
data. In order to evaluate potential confounding factors, other attempts were made to 
analyze the data. For example by using the clinical data of the two sites facing the biopsy 
only, instead of using all six sites around the implant. Another attempt was made in order to 
investigate more pronounced mucositis reactions, by stratifying the data according to PCR at 
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another attempt using the best 20% versus the worst 20% of cleaners was performed. 
However, very similar outcomes were obtained with the same negative tendencies for group 
Zr-h in regards to histologic outcomes, and therefore, this attempt was discarded. Vice versa, 
this can be interpreted as a success of randomization.
Considering the large number of performed statistical models, the presented differences must 
be interpreted with caution. Although the study is based on a robust design, some limitations 
have to be kept in mind. The number of patients is a limiting factor, especially in respect to 
the histometric outcomes, as not all biopsies could be evaluated. Compared to block sections 
in animal studies, the predictability of tissue removal and measuring is inferior. The 
experimental mucositis experiment could have provoked a more distinct inflammatory 
reaction. It is recommended to use splints in order to achieve this goal. The proximity of the 
two sites can also be considered as a limitation, with sites potentially influencing each other. 
Ideally, the geometry of the implants should be absolutely similar. Although the soft tissue 
neck was similar, the titanium implant carried a healing abutment and therefore also had a 
microgap. For the zirconia implant, it was decided not to use the available PEEK cap in order 
to avoid a different material. Zirconia caps were considered, but this would have introduced a 
cement margin. Having no cap on the zirconia implant seemed to be the best solution, but 
led to frequent soft tissue growth over the implant shoulder, which might have affected the 
accessibility for probing. Furthermore, the evaluation of immunological factors has not been 
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Conclusions
The present randomized controlled clinical trial revealed similar clinical outcomes for zirconia 
and titanium dental implants under healthy conditions. Lower plaque and bleeding scores 
were found around zirconia implants under experimental mucositis conditions. No significant 
differences between groups were found for the majority of the histological results, including 
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Figure Legend
Figure 1a-c Implant placement; a) after flap elevation; b) after implant placement; c) at the 
end of surgery.
Figure 2a-d Biopsy removal after experimental mucositis phase; a) healing abutment 
removal (Ti implant) and incision design; b+c) buccal suture in order to mark the orientation 
of the biopsy; d) healing cap/abutment and inverting mattress suture.
Figure 3a-c Histologies displaying; a) placement of regions of interest underneath the oral 
epithelium, sulcular epithelium, junctional epithelium and supracrestal connective tissue at 
the left side and measurement of the length of the junctional epithelium and soft tissue 
thickness at the right side; b) representative biopsy showing a long junctional epithelium at 
both sides and a clear inflammatory infiltrate at the right side (group Zr-h) from a patient 
with very good plaque control; c) representative biopsy with a both-sided short junctional 
epithelium and a very clear collagen fiber orientation in the center.
Figure 4a-c Boxplot illustration of clinical findings before (Baseline) and after (3 weeks) the 
experimental mucositis experiment and histologic findings at 3 weeks: a) Plaque control 
record (PCR); b)bleeding on probing (BoP); c) Histomorphometrically evaluated number of 
inflammatory cells at the level of the junctional epithelium; Zr-h = zirconia implant, healthy; 
Ti-h = titanium implant, healthy; Zr-m = zirconia implant, mucositis; Ti-m = titanium 
implant, mucositis; All medians which are not clearly visible are overlapping with the first 
(25%, lower) quartile; Whiskers: 10-90 percentile.
Table 1 Baseline characteristics of patients/implants. Zr-h = zirconia implant, healthy; Ti-h 
= titanium implant, healthy; Zr-m = zirconia implant, mucositis; Ti-m = titanium implant, 
mucositis; Q1 = 25% quartile; Q3 = 75% quartile.
Table 2 Descriptive data of all clinical parameters. N = number; SD = standard deviation; 
Min = minimum; Q1 25% quartile; Q3 = 75% quartile; Max = maximum; PCR = plaque 
control record; BoP = bleeding on probing; PD = probing depth; KT = keratinized tissue; Zr-
h = Zirconia implant, healthy; Ti-h = Titanium implant, healthy; Zr-m = Zirconia implant, 
mucositis; Ti-m = Titanium implant, mucositis.
Table 3 Descriptive data of histomorphometric analysis. N = number; SD = standard 
deviation; Min = minimum; Q1 25% quartile; Q3 = 75% quartile; Max = maximum; JE 
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epithelium; SE = sulcular epithelium; JE = junctional epithelium; CT = supracrestal 
connective tissue; Zr-h = Zirconia implant, healthy; Ti-h = Titanium implant, healthy; Zr-m 
= Zirconia implant, mucositis; Ti-m = Titanium implant, mucositis.
Appendix 1 Microbiological parameters. N = number; SD = standard deviation; Min = 
minimum; Q1 25% quartile; Q3 = 75% quartile; Max = maximum; TBL = total bacterial 
load; Marker pathogen = presence of a marker pathogen; Zr-h = Zirconia implant, healthy; 
Ti-h = Titanium implant, healthy; Zr-m = Zirconia implant, mucositis; Ti-m = Titanium 
implant, mucositis.
Appendix 2 Pairwise comparisons of Ti - Zr under healthy and under mucositis conditions 
with parametric and non-parametric 95%-confidence intervals (CI). PCR = plaque control 
record; BoP = bleeding on probing; PD = probing depth; JE inflammcells = inflammatory cells 
at the level of the junctional epithelium; JE length = length of the junctional epithelium; Zr-h 
= Zirconia implant, healthy; Ti-h = Titanium implant, healthy; Zr-m = Zirconia implant, 
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Group Zr-h Ti-h Zr-m Ti-m Total 
Number  Patients 20 20 40 
Implants 20 20 20 20 80 
Gender Male  8 (40%) 14 (70%) 22 (55.0%) 
Female  12 (60%) 6 (30%) 18 (45.0%) 
Age  Median 52.5 62.1 55.4 
Quartile (first;third) 36.8;61.3 51.5;69.5 45.6;65.3 
Smoking Up to 20 Cig/day 4 (20%) 6 (30%) 10 (25%) 
Former Smoker 4 (20%) 7 (35%) 11 (27.5%) 
Jaw Maxilla 5 (25%) 9 (45%) 14 (35%) 
Mandible 15 (75%) 11 (55%) 26 (65%) 
Site Premolar 10 (50%) 7 (35%) 13 (65%) 9 (45%) 39 (48.75%) 
Molar 10 (50%) 13 (65%) 7 (35%) 11 (55%) 41 (51.25%) 
Augmentations Dehiscence 3 (15%) 3 (15%) 4 (20%) 4 (20%) 12 (15%) 
Intrabony defect 1 (5%) 1 (5%) 0 (0%) 0 (0%) 2 (2.5%) 
Crestal sinus lift 0 (0%) 0 (0%) 1 (5%) 1 (5%) 2 (2.5%) 
 
 












Zr-h 20 10.83 21.13 0.00 0.00 0.00 16.67 66.67 
Ti-h 20 14.17 23.74 0.00 0.00 0.00 16.67 100 
Zr-m 20 4.17 7.40 0.00 0.00 0.00 8.33 16.67 
Ti-m 20 14.17 27.19 0.00 0.00 0.00 16.67 100 
BoP (%) 
Zr-h 20 22.50 20.43 0.00 12.50 16.67 33.33 66.67 
Ti-h 20 15.83 18.32 0.00 0.00 16.67 25.00 50.00 
Zr-m 20 22.50 23.74 0.00 0.00 16.67 41.67 83.33 
Ti-m 20 20.83 18.63 0.00 0.00 16.67 33.33 66.67 
PD (mm) 
Zr-h 20 2.58 0.47 1.50 2.25 2.58 3.00 3.17 
Ti-h 20 2.71 0.55 1.67 2.33 2.67 3.08 3.67 
Zr-m 20 2.67 0.46 1.67 2.33 2.83 3.00 3.17 
Ti-m 20 2.74 0.67 1.00 2.50 2.75 3.00 4.00 
KT (mm) 
Zr-h 20 3.30 1.45 1.00 2.00 3.00 4.00 7.00 
Ti-h 20 3.40 1.57 2.00 2.00 3.00 4.00 8.00 
Zr-m 20 3.10 1.25 1.00 2.00 3.00 4.00 6.00 














Zr-h 20 12.50 16.99 0.00 0.00 0.00 33.33 50.00 
Ti-h 20 14.17 18.95 0.00 0.00 8.33 16.67 66.67 
Zr-m 20 68.33 31.94 0.00 50.00 66.67 100 100 
Ti-m 20 75.00 29.37 0.00 58.33 83.33 100 100 
BoP (%) 
Zr-h 20 11.67 18.81 0.00 0.00 0.00 16.67 66.67 
Ti-h 20 11.67 16.31 0.00 0.00 0.00 16.67 50.00 
Zr-m 20 21.67 23.63 0.00 0.00 16.67 33.33 83.33 
Ti-m 20 32.50 27.82 0.00 16.67 16.67 58.33 83.33 
PD (mm) 
Zr-h 20 2.56 0.35 2.00 2.25 2.67 2.83 3.00 
Ti-h 20 2.53 0.30 2.00 2.25 2.50 2.83 3.00 
Zr-m 20 2.37 0.40 1.67 2.08 2.33 2.75 3.00 
Ti-m 20 2.63 0.38 2.00 2.33 2.67 3.00 3.33 
KT (mm) 
Zr-h 20 3.45 1.39 1.00 2.00 3.00 5.00 6.00 
Ti-h 20 3.05 1.64 1.00 2.00 3.00 3.50 8.00 
Zr-m 19 3.47 1.43 2.00 2.00 3.00 5.00 6.00 
Ti-m 19 3.05 1.51 0.00 2.00 3.00 4.00 6.00 
 
 
















Zr-h 8 1213.46 243.32 875.27 1005.28 1243.81 1359.91 1614.39 
Ti-h 8 1344.59 430.08 536.26 1129.74 1354.76 1687.08 1877.28 
Zr-m 14 1664.80 668.79 928.87 1238.46 1498.70 1919.56 3579.82 




Zr-h 8 1924.87 476.27 1284.06 1518.45 1930.02 2335.29 2547.33 
Ti-h 8 2056.40 431.89 1646.92 1707.69 1931.42 2334.95 2856.19 
Zr-m 14 2484.78 431.25 1942.08 2121.53 2433.61 2681.39 3382.23 
Ti-m 14 2387.24 510.37 1731.10 1908.36 2371.46 2763.18 3442.96 
JE/BW 
ratio (%) 
Zr-h 8 64.45 10.92 51.68 57.26 58.75 76.38 79.15 
Ti-h 8 65.92 20.28 30.19 57.58 65.39 76.43 98.37 
Zr-m 14 66.66 22.06 43.78 54.61 57.95 71.60 122.27 






















Zr-h 19 0.48 0.83 0.06 0.12 0.23 0.38 3.72 
Ti-h 19 0.83 2.01 0.07 0.14 0.29 0.38 8.87 
Zr-m 19 0.31 0.24 0.08 0.14 0.20 0.41 0.83 
Ti-m 19 0.33 0.33 0.03 0.12 0.28 0.42 1.30 
SE (%) 
Zr-h 20 1.27 2.47 0.00 0.23 0.42 1.03 11.05 
Ti-h 20 1.08 1.76 0.05 0.19 0.35 0.98 6.53 
Zr-m 19 0.98 1.17 0.00 0.20 0.56 1.07 4.18 
Ti-m 19 0.55 0.52 0.00 0.12 0.27 0.95 1.90 
JE (%) 
Zr-h 20 4.80 5.65 0.07 0.52 2.34 7.20 20.20 
Ti-h 20 3.11 5.70 0.07 0.49 1.34 3.00 25.98 
Zr-m 19 1.95 3.18 0.21 0.34 0.65 2.70 14.03 
Ti-m 19 2.24 3.10 0.08 0.27 0.72 3.35 10.48 
CT (%) 
Zr-h 18 1.84 2.43 0.05 0.21 0.48 3.82 7.10 
Ti-h 19 0.95 1.13 0.04 0.15 0.43 1.32 3.63 
Zr-m 19 1.17 1.29 0.05 0.27 0.52 1.66 3.97 

















Zr-h 19 5.57 3.07 2.23 2.70 4.18 7.88 11.72 
Ti-h 19 4.87 2.20 2.41 3.34 4.25 6.01 11.10 
Zr-m 19 4.06 2.23 1.65 2.41 3.55 5.08 11.65 
Ti-m 19 4.49 1.46 2.11 3.46 4.35 5.27 8.54 
SE (%) 
Zr-h 20 5.44 2.72 1.80 3.30 4.83 7.32 10.77 
Ti-h 20 4.32 2.19 1.16 2.73 3.96 5.86 9.21 
Zr-m 19 5.36 2.12 1.76 3.38 5.33 6.53 9.44 
Ti-m 19 4.11 1.62 1.70 2.85 4.12 5.01 7.33 
JE (%) 
Zr-h 20 6.29 3.62 2.36 3.60 6.01 7.40 18.42 
Ti-h 20 3.88 1.26 2.27 2.93 3.48 4.88 7.24 
Zr-m 19 5.52 3.88 1.47 3.34 4.79 6.65 19.52 
Ti-m 19 4.56 2.71 2.00 2.77 3.96 4.94 13.46 
CT (%) 
Zr-h 18 5.29 3.67 1.27 2.80 4.51 6.63 14.80 
Ti-h 19 3.92 2.16 0.87 2.49 3.74 4.98 10.04 
Zr-m 19 3.97 1.98 1.00 2.05 3.89 5.72 7.96 




























































 TBL (n, millions) 
Zr-h 20 27.97 26.24 0.29 3.71 21.42 45.73 78.35 
Ti-h 20 29.14 28.66 0.03 6.34 18.10 39.21 97.67 
Zr-m 18 18.05 14.12 1.28 5.46 16.33 28.12 51.79 
Ti-m 18 15.30 14.95 0.93 2.14 13.24 18.45 53.40 
Marker pathogen 
(%) 
Zr-h 20 5.00 22.00 0.00 0.00 0.00 0.00 100.00 
Ti-h 20 15.00 37.00 0.00 0.00 0.00 0.00 100.00 
Zr-m 18 17.00 38.00 0.00 0.00 0.00 0.00 100.00 












TBL (n, millions) 
Zr-h 20 16.20 15.89 0.14 3.61 10.27 26.96 49.96 
Ti-h 20 20.20 22.69 0.14 6.29 11.78 25.89 89.53 
Zr-m 18 25.99 22.05 2.20 7.00 20.62 43.87 66.53 
Ti-m 18 21.69 22.61 1.14 4.31 16.34 31.85 88.12 
Marker pathogen 
(%) 
Zr-h 20 5.00 22.00 0.00 0.00 0.00 0.00 100.00 
Ti-h 20 5.00 22.00 0.00 0.00 0.00 0.00 100.00 
Zr-m 19 16.00 37.00 0.00 0.00 0.00 0.00 100.00 






















Ti-h – Zr-h 0.00   0.00 0.17 
Ti-m – Zr-m 0.00   0.00 0.17 
BoP (%) 
Ti-h – Zr-h 0.00   -0.17 0.00 
Ti-m – Zr-m 0.00   -0.17 0.17 
PD (mm) 
Ti-h – Zr-h   0.12 0.04 0.20 














Ti-h – Zr-h 0.00   0.00 0.17 
Ti-m – Zr-m 0.00   -0.17 0.17 
BoP (%) 
Ti-h – Zr-h 0.00   -0.17 0.00 
Ti-m – Zr-m 0.17   0.00 0.17 
PD (mm) 
Ti-h – Zr-h   -0.03 -0.08 0.01 













 JE inflammcells 
(%) 
Ti-h – Zr-h -0.99   -4.22 0.68 
Ti-m – Zr-m 0.03   -1.05 1.07 
JE length (µm) Ti-h – Zr-h   99.11 -56.57 254.79 
Ti-m – Zr-m   -86.69 -183.05 9.66 
 
